These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 3485408)
1. Ankylosing spondylitis, HLA-B27, and Klebsiella: a study of lymphocyte reactivity of anti-Klebsiella sera. Singh B; Milton JD; Woodrow JC Ann Rheum Dis; 1986 Mar; 45(3):190-7. PubMed ID: 3485408 [TBL] [Abstract][Full Text] [Related]
2. Effect of klebsiella capsular antisera on lymphocytes from patients with ankylosing spondylitis. Shinebaum R; Cooke EM; Siegerstetter J; Wright V J Med Microbiol; 1981 Nov; 14(4):451-6. PubMed ID: 7310846 [TBL] [Abstract][Full Text] [Related]
3. A reinvestigation of the cross-reactivity between Klebsiella and HLA-B27 in the aetiology of ankylosing spondylitis. Georgopoulos K; Dick WC; Goodacre JA; Pain RH Clin Exp Immunol; 1985 Dec; 62(3):662-71. PubMed ID: 3878755 [TBL] [Abstract][Full Text] [Related]
4. An antiserum to a disease-associated factor from the cells of an HLA-B27 positive patient with ankylosing spondylitis specifically recognizes an HLA-B27 associated determinant. Sullivan JS; Geczy AF Arthritis Rheum; 1987 Apr; 30(4):439-42. PubMed ID: 2437933 [TBL] [Abstract][Full Text] [Related]
5. The role of Klebsiella in the pathogenesis of ankylosing spondylitis. II Evidence for a specific B27-associated marker on the lymphocytes of patients with ankylosing spondylitis. Geczy AF; Seager K; Bashir HV; de Vere-Tyndall A; Edmonds J J Clin Lab Immunol; 1980 Jan; 3(1):23-8. PubMed ID: 7381924 [TBL] [Abstract][Full Text] [Related]
6. Antiserum to Klebsiella K43 BTS 1 specifically lyses lymphocytes of HLA-B27-positive patients with ankylosing spondylitis from a London population. Archer JR; Stubbs MM; Currey HL; Geczy AF Lancet; 1985 Feb; 1(8424):344-5. PubMed ID: 2857398 [No Abstract] [Full Text] [Related]
7. Blind confirmation of Geczy factor in ankylosing spondylitis. van Rood JJ; van Leeuwen A; Ivanyi P; Cats A; Breur-Vriesendorp BS; Dekker-Saeys AJ; Kijlstra A; van Kregten E Lancet; 1985 Oct; 2(8461):943-4. PubMed ID: 2865436 [No Abstract] [Full Text] [Related]
8. Cross-reactivity of anti-Klebsiella K43 BTS 1 serum and lymphocytes of patients with ankylosing spondylitis: antipodean curiosity? Geczy AF; Prendergast JK; McGuigan LE; Upfold LI; Sullivan JS Lancet; 1985 May; 1(8438):1169. PubMed ID: 2860379 [No Abstract] [Full Text] [Related]
9. The distribution of a specific HLA-B27-associated cell surface component on the tissues of patients with ankylosing spondylitis. Alexander K; Edwards C; Misko IS; Geczy AF; Bashir HV; Edmonds JP Clin Exp Immunol; 1981 Jul; 45(1):158-64. PubMed ID: 6171370 [TBL] [Abstract][Full Text] [Related]
10. Cross-reactivity of anti-Klebsiella K43 antiserum and lymphocytes from HLA-B27-positive patients with ankylosing spondylitis. Struthers GR Lancet; 1985 Mar; 1(8431):764. PubMed ID: 2858037 [No Abstract] [Full Text] [Related]
11. Trial and error in producing ankylosing-spondylitis-selective antisera according to Andrew Geczy. Beukelman CJ; Quarles van Ufford HC; van Bree FP; Aerts PC; Nieuwenhoff C; Reerink G; van Leeuwen A; van Dijk H Scand J Rheumatol Suppl; 1990; 87():74-9; discussion 79-80. PubMed ID: 2259890 [TBL] [Abstract][Full Text] [Related]
12. The use of enzyme immunoassay (EIA) and radiobinding assay to investigate the cross-reactivity of Klebsiella antigens and HLA B27 in ankylosing spondylitis patients and healthy controls. Baines M; Ebringer A; Avakian H; Samuel D; James DC Scand J Rheumatol; 1990; 19(5):341-9. PubMed ID: 1699267 [TBL] [Abstract][Full Text] [Related]
13. IgA antibodies against Klebsiella and other Gram-negative bacteria in ankylosing spondylitis and acute anterior uveitis. Sprenkels SH; Van Kregten E; Feltkamp TE Clin Rheumatol; 1996 Jan; 15 Suppl 1():48-51. PubMed ID: 8835503 [TBL] [Abstract][Full Text] [Related]
14. Ankylosing spondylitis, HLA-B27, and klebsiella. Geczy AF Ann Rheum Dis; 1986 Mar; 45(3):261-2. PubMed ID: 3485411 [No Abstract] [Full Text] [Related]
15. [Ankylosing spondylarthritis, HLA B27 and the theory of crossed tolerance]. Ebringer A Rev Rhum Mal Osteoartic; 1983 Nov; 50(11):763-9. PubMed ID: 6364315 [TBL] [Abstract][Full Text] [Related]
16. Search for Klebsiella cell wall components cross-reactive with lymphocytes of B27+ AS+ individuals. Druery C; Bashir H; Geczy AF; Alexander K; Edmonds J Hum Immunol; 1980 Sep; 1(2):151-60. PubMed ID: 7021488 [TBL] [Abstract][Full Text] [Related]
17. Failure of Klebsiella pneumoniae antibodies to cross-react with peripheral blood mononuclear cells from patients with ankylosing spondylitis. Cameron FH; Russell PJ; Easter JF; Wakefield D; March L Arthritis Rheum; 1987 Mar; 30(3):300-5. PubMed ID: 3551965 [TBL] [Abstract][Full Text] [Related]
18. HLA-B27 associated cross-reactive marker on the cells of New Zealand patients with ankylosing spondylitis. McGuigan LE; Geczy AF; Prendergast JK; Edmonds JP; Hart HH; Bashir HV Ann Rheum Dis; 1986 Feb; 45(2):144-8. PubMed ID: 3484937 [TBL] [Abstract][Full Text] [Related]
19. Ankylosing spondylitis, HLA-B27 and Klebsiella. I. Cross-reactivity studies with rabbit antisera. Welsh J; Avakian H; Cowling P; Ebringer A; Wooley P; Panayi G; Ebringer R Br J Exp Pathol; 1980 Feb; 61(1):85-91. PubMed ID: 6769456 [TBL] [Abstract][Full Text] [Related]